Search results for "Lute"

showing 10 items of 1384 documents

Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial …

2016

Summary Background Women with a history of venous thromboembolism (VTE) have a 2% to 10% absolute risk of VTE recurrence during subsequent pregnancies. Therefore, current guidelines recommend that all pregnant women with a history of VTE receive pharmacologic thromboprophylaxis. The optimal dose of low-molecular-weight heparin (LMWH) for thromboprophylaxis is unknown. In the Highlow study (NCT 01828697; www.highlowstudy.org ), we compare a fixed low dose of LMWH with an intermediate dose of LMWH for the prevention of pregnancy-associated recurrent VTE. We present the rationale and design features of this study. Methods The Highlow study is an investigator-initiated, multicentre, internation…

Adultmedicine.medical_specialtymedicine.drug_classPregnancy Complications CardiovascularLow molecular weight heparinHemorrhage030204 cardiovascular system & hematologylaw.inventionYoung Adult03 medical and health sciencesClinical trials0302 clinical medicineRandomized controlled trialRecurrencePregnancylawInternal medicineVenous thrombosisSecondary PreventionHumansMedicinecardiovascular diseasesPregnancy030219 obstetrics & reproductive medicineProphylaxisbusiness.industryPostpartum PeriodAbsolute risk reductionAnticoagulantsVenous ThromboembolismHematologyHeparinHeparin Low-Molecular-Weightmedicine.diseaseequipment and suppliesLMWHSurgeryClinical trialVenous thrombosisTreatment OutcomeGestationFemalebusinessmedicine.drug
researchProduct

Absolute lymphocyte count is unrelated to overall survival in newly diagnosed elderly patients with multiple myeloma treated with immunomodulatory dr…

2015

The absolute lymphocyte count (ALC) has been widely studied in hematologic and solid malignancies as a marker of host antitumor immunity. Its significance has been evaluated in multiple myeloma (MM...

Aged 80 and overMaleCancer ResearchAntitumor immunitybusiness.industryAbsolute lymphocyte countAntineoplastic AgentsHematologyNewly diagnosedMiddle AgedPrognosismedicine.diseaseOncologyImmunologyOverall survivalHumansImmunologic FactorsMedicineFemaleLymphocyte CountAbsolute lymphocyte count multiple meyolmaMultiple MyelomabusinessMultiple myelomaAgedLeukemia & Lymphoma
researchProduct

Genetic and environmental influences on hearing at different frequencies separately for the better and worse hearing ear in older women

2007

The purpose of the present study was to examine the relative contribution of genetic and environmental effects on the air-conducted hearing threshold levels at low (0.125-0.5 kHz), mid (1-2 kHz), and high (4-8 kHz) frequencies separately for the better and worse hearing ear in older women. We also examined the distribution of audiogram configurations. Data was analysed using quantitative genetic modelling. As part of the Finnish twin study on aging (FITSA), hearing was measured in 103 monozygotic and 114 dizygotic female twin pairs aged 63-76 years. Approximately every third subject had a flat type, and two-thirds a descending type of audiogram configuration. No significant difference was o…

AgingLinguistics and Languagemedicine.medical_specialtyAudiologySeverity of Illness IndexLanguage and Linguistics03 medical and health sciencesSpeech and Hearing0302 clinical medicineDiseases in TwinsTwins Dizygoticotorhinolaryngologic diseasesHumansMedicineAdditive genetic effectsRegistries030223 otorhinolaryngology10. No inequalityHearing DisordersFinlandAgedAbsolute threshold of hearingmedicine.diagnostic_testbusiness.industrySignificant differenceAuditory ThresholdEnvironmental ExposureAudiogramMiddle AgedHeritabilityTwin studyZygosityFemalePure tone audiometrybusiness030217 neurology & neurosurgeryInternational Journal of Audiology
researchProduct

Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning methods: a large pop…

2021

Abstract Background In increasingly ageing populations, there is an emergent need to develop a robust prediction model for estimating an individual absolute risk for all-cause mortality, so that relevant assessments and interventions can be targeted appropriately. The objective of the study was to derive, evaluate and validate (internally and externally) a risk prediction model allowing rapid estimations of an absolute risk of all-cause mortality in the following 10 years. Methods For the model development, data came from English Longitudinal Study of Ageing study, which comprised 9154 population-representative individuals aged 50–75 years, 1240 (13.5%) of whom died during the 10-year follo…

AgingLongitudinal studySurvivalEpidemiologyCalibration (statistics)PopulationHealth InformaticsFeature selectionAbsolute riskPopulation-based longitudinal studyPrognostic factorsRisk AssessmentSensitivity and Specificity01 natural sciencesCohort Studies010104 statistics & probability03 medical and health sciences0302 clinical medicineStatisticsHumansMedicineLongitudinal Studies030212 general & internal medicineMortality0101 mathematicseducationAgedProportional Hazards Modelslcsh:R5-920education.field_of_studyProportional hazards modelbusiness.industryAbsolute risk reductionHealth and Retirement StudyStatistical learninglcsh:Medicine (General)businessResearch ArticleCohort studyBMC Medical Research Methodology
researchProduct

Hearing as a Predictor of Falls and Postural Balance in Older Female Twins

2009

BACKGROUND: The purpose of the present study was to examine, first, whether hearing acuity predicts falls and whether the potential association is explained by postural balance and, second, to examine whether shared genetic or environmental effects underlie these associations. METHODS: Hearing was measured using a clinical audiometer as a part of the Finnish Twin Study on Aging in 103 monozygotic and 114 dizygotic female twin pairs aged 63-76 years. Postural balance was indicated as a center of pressure (COP) movement in semitandem stance, and participants filled in a fall-calendar daily for an average of 345 days after the baseline. RESULTS: Mean hearing acuity (better ear hearing threshol…

Agingmedicine.medical_specialtyHearing lossTwinsPoison controlAudiologyRisk AssessmentSensitivity and SpecificitySampling Studies03 medical and health sciences0302 clinical medicineAudiometryHearingPredictive Value of TestsConfidence IntervalsTwins Dizygoticotorhinolaryngologic diseasesPostural BalanceHumansMedicineHearing Loss030223 otorhinolaryngologyPostural BalanceAudiometerFinlandAgedAbsolute threshold of hearingmedicine.diagnostic_testbusiness.industryIncidenceTwins MonozygoticMiddle AgedJournal of Gerontology: Medical SciencesTwin studyQuartileAccidental FallsFemaleGeriatrics and Gerontologymedicine.symptomAudiometrybusiness030217 neurology & neurosurgeryThe Journals of Gerontology Series A: Biological Sciences and Medical Sciences
researchProduct

Genetic and environmental influences on hearing in older women.

2007

Background. This study examined the relative contribution of genetic and environmental effects on the air-conducted hearing threshold level (0.5‐4 kHz) and speech recognition threshold level of the better ear as well as self-reported hearing in older women. Methods. Hearing was measured as a part of the Finnish Twin Study on Aging in 103 monozygotic (MZ) and 114 dizygotic (DZ) female twin pairs aged 63‐76 years. Audiometric measured hearing was tested using standardized methods in soundproof conditions. Self-reported hearing was assessed by a structured question. Quantitative genetic modeling was used for data analyses. Results. No significant differences in age, exposure to noise, hearing-…

Agingmedicine.medical_specialtyIndividualityBivariate analysisAudiologyEnvironmentCohort StudiesAudiometryHearingGenetic modelingotorhinolaryngologic diseasesTwins DizygoticMedicineHumansAgedAbsolute threshold of hearingModels GeneticSpeech Reception Threshold Testbusiness.industryContrast (statistics)Auditory ThresholdTwins MonozygoticMiddle AgedTwin studyConfidence intervalSpeech PerceptionFemaleGeriatrics and GerontologybusinessThe journals of gerontology. Series A, Biological sciences and medical sciences
researchProduct

The value of neutrophil and lymphocyte count in frail older women.

2013

Increasing evidence suggests that systemic inflammation is associated with many pathophysiological processes including frailty in older adults. We evaluated the relationships between white blood cell subtypes, geriatric assessment, and frailty syndrome and in particular, how they correlate with individual frailty criteria (involuntary loss of weight, low energy or exhaustion, slow mobility, muscle weakness, and low physical activity) in frail older women. There was a significant and positive correlation between the frailty score and neutrophil count, but a significantly negative correlation was found when this score was compared to the lymphocyte count. These associations were significant o…

Agingmedicine.medical_specialtyNeutrophilsLymphocyteFrail ElderlyFrailty syndromePilot ProjectsSystemic inflammationPhysical strengthBiochemistryLeukocyte CountEndocrinologyWeight lossWhite blood cellInternal medicineWeight LossGeneticsmedicineHumansLymphocyte CountLymphocytesMuscle StrengthMolecular BiologyExerciseGeriatric AssessmentAged 80 and overHand Strengthbusiness.industryMuscle weaknessCell Biologymedicine.diseasemedicine.anatomical_structureCross-Sectional StudiesImmune System DiseasesPhysical FitnessPhysical therapyAbsolute neutrophil countFemalemedicine.symptombusinessExperimental gerontology
researchProduct

Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist…

2005

Background This descriptive study evaluates the impact on endometrial development of standard and high doses of a GnRH antagonist in stimulated cycles compared with GnRH agonist and natural cycles. Methods Thirty-one oocyte donors were treated with a combination of rFSH and 0.25 mg/day ganirelix (standard dose), 2 mg/day ganirelix (high dose) or 0.6 mg/day buserelin (long protocol). Vaginal progesterone (200 mg/day) was administered in the luteal phase. Endometrial biopsies were performed 2 and 7 days after HCG administration. Additional biopsies were carried out in a subset of 12 subjects, 2 and 7 days following the LH peak of their previous natural cycle. Biopsies were evaluated histologi…

AgonistAdultendocrine systemmedicine.medical_specialtyTime FactorsAdolescentmedicine.drug_classmedicine.medical_treatmentFertilization in VitroLuteal phaseBiologyLuteal PhaseEndometriumBuserelinChorionic GonadotropinGonadotropin-releasing hormone antagonistGonadotropin-Releasing HormoneEndometriumOvulation InductionInternal medicinemedicineHumansUltrasonicsGanirelixOligonucleotide Array Sequence Analysismedicine.diagnostic_testOocyte DonationRehabilitationObstetrics and GynecologyBuserelinmedicine.anatomical_structureEndocrinologyReproductive MedicineGene Expression RegulationReceptors EstrogenMicroscopy Electron ScanningOocytesRNAOvulation inductionFemaleFollicle Stimulating HormoneReceptors Progesteronehormones hormone substitutes and hormone antagonistsmedicine.drugEndometrial biopsyHuman reproduction (Oxford, England)
researchProduct

Pretreatment with gonadotropin-releasing hormone (GnRH) antagonists to prevent the flare-up effect of long-acting GnRH agonists: results of a pilot s…

2007

This study evaluated in vivo whether the flare-up effect of GnRH agonists can be suppressed through pretreatment with a GnRH antagonist. The classic flare-up effect caused by 3.8 mg goserelin acetate could not be suppressed through pretreatment using a single dosage of 3.24 mg cetrorelix acetate.

AgonistMaleendocrine systemmedicine.medical_specialtyTime Factorsmedicine.drug_classPilot ProjectsGonadotropin-releasing hormoneGonadotropin-Releasing HormoneHormone AntagonistsIn vivoInternal medicinemedicineFlare upHumansTestosteroneEstradiolbusiness.industryGoserelin AcetateAntagonistObstetrics and GynecologyLuteinizing HormoneLong actingEndocrinologyTreatment OutcomeReproductive MedicineCetrorelixGoserelinFemaleFollicle Stimulating Hormone Humanbusinesshormones hormone substitutes and hormone antagonistsTranssexualismmedicine.drugFertility and sterility
researchProduct

Synthesis and pharmacological characterization of beta2-adrenergic agonist enantiomers: zilpaterol.

2009

The beta-adrenergic agonist 1 (zilpaterol) is used as production enhancer in cattle. Binding experiments of separated enantiomers on recombinant human beta(2)-adrenergic and mu-opioid receptors and functional studies showed that the (-)-1 enantiomer accounts for essentially all the beta(2)-adrenergic agonist activity and that it exhibits less affinity toward the mu-opioid receptor than (+)-1, which is a mu-opioid receptor antagonist. X-ray crystallography revealed the absolute configuration of (-)-1 to be 6R,7R.

AgonistTrimethylsilyl CompoundsStereochemistrymedicine.drug_classZilpaterolAbsolute configurationBiological activityStereoisomerismPharmacologyAdrenergic beta-AgonistsReceptor antagonistCrystallography X-RayRecombinant Proteinschemistry.chemical_compoundchemistryDrug DiscoverymedicineMolecular MedicineHumansEnantiomerReceptorBeta (finance)Adrenergic beta-2 Receptor AgonistsChromatography High Pressure LiquidJournal of medicinal chemistry
researchProduct